Beneficial effects of L-arginine-nitric oxide-producing pathway in rats treated with alloxan

Journal of Physiology

Volumn 584, Issue 3, 2007, Pages 921-933

  Vasilijević, Ana ^a   Buzadžić, Biljana ^a   Korać, Aleksandra ^a   Petrović, Vesna ^a   Janković, Aleksandra ^a   Korać, Bato ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; ARGININE; CYCLINE; GLUCOSE; GLUTATHIONE PEROXIDASE; I KAPPA B KINASE BETA; INSULIN; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRANSCRIPTION FACTOR PDX 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; INSULIN BLOOD LEVEL; MALE; NEWBORN; NONHUMAN; OXIDATION REDUCTION STATE; PANCREAS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT CHANGE; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; BLOOD LEVEL; CONFOCAL MICROSCOPY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; GLUCONEOGENESIS; IMMUNOHISTOCHEMISTRY; MOLECULAR DYNAMICS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ALLOXAN; ANIMALS; ANTIOXIDANTS; ARGININE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; IN SITU NICK-END LABELING; INSULIN-SECRETING CELLS; MALE; NF-KAPPA B; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN ISOFORMS; RATS; TRANS-ACTIVATORS;

EID: 35648995326     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.140277     Document Type: Article

References (77)

1. Ahlgren U, Jonsson J & Edlund H (1996). The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122, 1409-1416.
2. Archer SL & Hampl V (1992). N G - monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: Trouble in paradise. Biochem Biophys Res Commun 188, 590-596.
3. Baxter LC & Schofield PJ (1980). The effects of a high fat diet on chronic streptozotocin-diabetic rats. Diabetologia 18, 239-254.
4. Blachier F, Mourtada A, Sener A & Malaisse WJ (1989). Stimulus-secretion coupling of arginine-induced insulin release. Uptake of metabolized and nonmetabolized cationic amino acids by pancreatic islets. Endocrinology 124, 134-141.
5. Bouwens L & Kloppel G (1996). Islet cell neogenesis in the pancreas. Virchows Arch 427, 553-560.
6. Brand SJ, Tagerud S, Lambert P, Magil SG, Tatarkiewicz K, Doiron K & Yan Y (2002). Pharmacological treatment of chronic diabetes by stimulating pancreatic beta-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 91, 414-420.
7. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM & Herman AG (1990). Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 345, 346-347.
8. Carraway MS, Paintadosi CA, Jenkinson CP & Huang YC (1998). Differential expression of arginase and iNOS in the lung in sepsis. Exp Lung Res 24, 253-268.
9. Connelly L, Palacios-Callender M, Ameixa C, Moncada S & Hobbs AJ (2001). Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166, 3873-3881.
10. Das UN, Krishna MI, Vijay KK, Kumar SG & Chandra SC (1993). Beneficial effect of L-arginine in non-insulin dependent diabetes mellitus: A potential role for nitric oxide. Med Sci Res 21, 669-670.
11. De Haro Hernandez R, Cabrera-Munoz L & Mendez JD (2004). Regeneration of beta-cells and neogenesis from small ducts or acinar cells promote recovery of endocrine pancreatic function in alloxan-treated rats. Arch Med Res 35, 114-120.
12. DiMagno MJ, Hao Y, Tsunoda Y, Williams JA & Owyang C (2004). Secretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in mice. Am J Physiol Gastrointest Liver Physiol 286, G428-G436.
13. Ding Y & Rana RS (1998). Nitric oxide does not initiate but potentiates glucose-induced insulin secretion in pancreatic beta-cells. Biochem Biophys Res Commun 251, 699-703.
14. Dor Y, Brown J, Martinez OI & Melton DA (2004). Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429, 41-46.
15. Edlund H (1998). Transcribing pancreas. Diabetes 47, 1817-1823.
16. Friedewald WT, Levy RI & Fredrickson DS (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
17. Griffith OW (1980). Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106, 207-212.
18. Guttridge DC, Albanese C, Reuther JY, Pestell RG & Baldwin AS Jr (1999). NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19, 5785-5799.
19. Habig WH, Pabst MJ & Jakoby WB (1974). Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249, 7130-7139.
20. Henningsson R, Alm P, Lindstrom E & Lundquist I (2000). Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release. Am J Physiol Endocrinol Metab 279, E95-E107.
21. Huynh NT & Tayek JA (2002). Oral arginine reduces systemic blood pressure in type 2 diabetes: Its potential role in nitric oxide generation. J Am Coll Nutr 21, 422-427.
22. Ikemoto M, Tsunekawa S, Tanaka K, Tanaka A, Yamaoka Y, Ozawa K, Fukuda Y, Moriyasu F, Totani M, Kasai Y, Mori T & Ueda K (1998). Liver-type arginase in serum during and after liver transplantation: A novel index in monitoring conditions of the liver graft and its clinical significance. Clin Chim Acta 271, 11-23.
23. Ivarsson R, Quintens R, Dejonghe S, Tsukamoto K, in 't Veld P, Renstrom E & Schuit FC (2005). Redox control of exocytosis: regulatory role of NADPH, thioredoxin, and glutaredoxin. Diabetes 54, 2132-2142.
24. Jelodar G, Razmi N & Gholapour V (2007). Arginase alteration in the reproductive system of alloxan-diabetic dogs. J Reprod Dev 53, 317-321.
25. Jimenez-Feltstrom J, Lunquist I, Obermuller S & Salehi A (2004). Insulin feedback actions: Complex effects involving isoforms of islet nitric oxide synthase. Regul Pept 122, 109-118.
26. Jones PM, Persaud SJ, Bjaaland T, Pearson JD & Howell SL (1992). Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans. Diabetologia 35, 1020-1027.
27. Jun T, Sakinis A & Wennmalm A (1995). The insulin secretory response to intravenous glucose in the rat is independent of NO formation. Acta Physiol Scand 155, 61-65.
28. Kaneto H, Fujii J, Seo HG, Suzuki H, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T & Taniguchi N (1995). Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44, 733-738.
29. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka T, Matsuhisa M & Yamasaki Y (2005). Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 37, 1595-1608.
30. Kim KY, Moon JI, Lee EJ, Lee YJ, Kim IB, Park CK, Oh SJ & Chun MH (2002). The effect of L-arginine, a nitric oxide synthase substrate, on retinal cell proliferation in the postnatal rat. Dev Neurosci 24, 313-321.
31. Knowles RG & Moncada S (1994). Nitric oxide synthases in mammals. Biochem J 298, 249-258.
32. Lajoix AD, Reggio H, Chardes T, Peraldi-Roux S, Tribillac F, Roye M, Dietz S, Broca C, Manteghetti M, Ribes G, Wollheim CB & Gross R (2001). A neuronal isoform of nitric oxide synthase expressed in pancreatic β-cells controls insulin secretion. Diabetes 50, 1311-1323.
33. Lardon J, De Breuck S, Rooman I, Van Lommel L, Kruhoffer M, Orntoft T, Schuit F & Bouwens L (2004 a). Plasticity in the adult rat pancreas: transdifferentiation of acinar exocrine to hepatocyte-like cells in primary culture. Hepatology 39, 1499-1507.
34. Lardon J, Huyens N, Rooman I & Bouwens L (2004 b). Exocrine cell transdifferentiation in dexamethasone-treated rat pancreas. Virchows Arch 444, 61-65.
35. Lazarow A (1952). Spontaneous recovery from alloxan diabetes in the rat. Diabetes 1, 363-372.
36. Lindsay RM, Smith W, Rossiter SP, McIntyre MA, Williams BC & Baird JD (1995). N omega-nitro-L-arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44, 365-368.
37. Lipsett MA, Austin EB, Castellarin ML, Lemay J & Rosenberg L (2006). Evidence for the homeostatic regulation of induced beta cell mass expansion. Diabetologia 49, 2910-2919.
38. Lowry OH, Rosenbrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
39. McKinnon CM & Docherty K (2001). Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia 44, 1203-1214.
40. Mendez JD & Balderas F (2001). Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetic rats. Biochimie 83, 453-458.
41. Méndez JD & De Haro Hernández R (2005). L-arginine and polyamine administration protect β-cells against alloxan diabetogenic effect in Sprague-Dawley rats. Biomed Pharmacother 59, 283-289.
42. Misra HP & Fridovich I (1972). The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247, 3170-3175.
43. Moellering D, McAndrew J, Patel RP, Cornwell T, Lincoln T, Cao X, Messina JL, Forman HJ, Jo H & Darley-Usmar VM (1998). Nitric oxide-dependent induction of glutathione synthesis through increased expression of γ-glutamylcysteine synthetase. Arch Biochem Biophys 358, 74-82.
44. Mohan IK & Das UN (1998). Effect of L-arginine-nitric oxide system on chemical-induced diabetes mellitus. Free Radic Biol Med 25, 757-765.
45. Moldovan S, Livingston E, Zhang RS, Kleinman R, Guth P & Brunicardi FC (1996). Glucose-induced islet hyperemia is mediated by nitric oxide. Am J Surg 171, 16-20.
46. Motterlini R, Foresti R, Bassi R, Calabrese V, Clark JE & Green CJ (2000). Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and S -nitrosothiols. J Biol Chem 275, 13613-13620.
47. Munder M, Eichmann K & Modolell M (1998). Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/ arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 160, 5347-5354.
48. Neuschwander-Tetri BA, Presti ME & Wells LD (1997). Glutathione synthesis in the exocrine pancreas. Pancreas 14, 342-349.
49. Oberley LW (1988). Free radicals and diabetes. Free Radic Biol Med 5, 113-124.
50. Ochoa JB, Bernard AC, Mistry SK, Morris SM Jr, Figert PL, Maley ME, Tsuei BJ, Boulanger BR & Kearney PA (2000). Trauma increases extrahepatic arginase activity. Surgery 127, 419-426.
51. Ochoa JB, Strange J, Kearney P, Gellin G, Endean E & Fitzpatrick E (2001). Effects of L-arginine on the proliferation of T lymphocyte subpopulations. J Parenter Enteral Nutr 25, 23-29.
52. Okamoto H, Akiyama T, Nata K, Ikeda T, Shervani NJ, Kawaguchi S, Yamauchi A, Onogawa T, Noguchi N & Takasawa S (2003). Reg (Regenerating gene) expression by PARP and NF-kB. Med Sci Monit 9, 50-60.
53. Paglia DE & Valentine WN (1967). Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidases. J Lab Clin Med 70, 158-169.
54. Patel AG, Toyama MT, Nguyen TN, Cohen GA, Ignarro LJ, Reber HA & Ashley SW (1995). Role of nitric oxide in the relationship of pancreatic blood flow and exocrine secretion in cats. Gastroenterology 108, 1215-1220.
55. Petrović V, Korać A, Buzadžić B & Korać B (2005). The effects of L-arginine and L-NAME supplementation on redox-regulation and thermogenesis in interscapular brown adipose tissue. J Exp Biol 208, 4263-4271.
56. Pieper GM & Dondlinger LA (1997). Plasma and vascular tissue arginine are decreased in diabetes: Acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharmacol Exp Ther 283, 684-691.
57. Pueyo ME, Gonzalez W, Pussard E & Arnal JF (1994). Insulin secretion in rats with chronic nitric oxide synthase blockade. Diabetologia 37, 879-884.
58. Rizzo MA & Piston DW (2003). Regulation of β cell glucokinase by S-nitrosylation and association with nitric oxide synthase. J Cell Biol 161, 243-248.
59. Robertson RP (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 279, 42351-42354.
60. Rodriguez PC, Quiceno DG & Ochoa AC (2007). L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 109, 1568-1573.
61. Rooman I & Bouwens L (2004). Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycemia in C57BI6/J mice treated with alloxan. Diabetologia 47, 259-265.
62. Rooman I, Lardon J & Bouwens L (2002). Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51, 686-690.
63. Saha SK, Ohinata H & Kuroshima A (1996). Effects of acute and chronic inhibition of nitric oxide synthase on brown adipose tissue thermogenesis. Jpn J Physiol 46, 375-382.
64. Salehi A, Carlberg M, Henningsson R & Lundquist I (1996). Islet constitutive nitric oxide synthase: Biochemical determination and regulatory function. Am J Physiol Cell Physiol 270, C1634-C1641.
65. Schmidt HH, Warner TD, Ishii K, Sheng H & Murad F (1992). Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 255, 721-723.
66. Siani A, Pagano E, Iacone R, Iacoviello L, Scopacasa F & Strazzullo P (2000). Blood pressure and metabolic changes during dietary l -arginine supplementation in humans. Am J Hypertens 13, 547-551.
67. Sjoholm A (1993). Role of polyamines in the regulation of proliferation and hormone production by insulin-secreting cells. Am J Physiol Cell Physiol 264, C501-C518.
68. Southan GJ & Szabo C (1996). Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51, 383-394.
69. Stickings P, Mistry SK, Boucher JL, Morris SM Jr & Cunningham JM (2002). Arginase expression and modulation of IL-1β-induced nitric oxide generation in rat and human islets of Langerhans. Nitric Oxide 7, 289-296.
70. Swenne I (1983). Effects of aging on the regenerative capacity of the pancreatic B-cell of the rat. Diabetes 32, 14-19.
71. Taboada MC, Rodriguez B, Millan R & Miguez I (2005). Role of dietary L-arginine supplementation on serum parameters and intestinal enzyme activities in rats fed an excess-fat diet. Biomed Pharmacother 60, 10-13.
72. Takada Y, Noguchi T, Okabe T & Kajiyama M (1982). Superoxide dismutase in various tissues from rabbits bearing the Vx-2 carcinoma in the maxillary sinus. Cancer Res 42, 4233-4235.
73. Tsuura Y, Ishida H, Shinomura T, Nishimura M & Seino Y (1998). Endogenous nitric oxide inhibits glucose-induced insulin secretion by suppression of phosphofructokinase activity in pancreatic islets. Biochem Biophys Res Commun 252, 34-38.
74. Winterbourn CC & Munday R (1989). Glutathione-mediated redox cycling of alloxan. Mechanisms of superoxide dismutase inhibition and of metal-catalyzed ·OH formation. Biochem Pharmacol 38, 271-277.
75. Witte MB, Thornton FJ, Tantry U & Barbul A (2002). L-arginine supplementation enhances diabetic wound healing: Involvement of the nitric oxide synthase and arginase pathways. Metabolism 51, 1269-1273.
76. Yago MD, Manas M, Ember Z & Singh J (2001). Nitric oxide and the pancreas: Morphological base and role in the control of the exocrine pancreatic secretion. Mol Cell Biochem 219, 107-120.
77. Zenilman ME, Chen J & Magnuson TH (1998). Effect of reg protein on rat pancreatic ductal cells. Pancreas 17, 256-261.